000 | 01939 a2200505 4500 | ||
---|---|---|---|
005 | 20250514223439.0 | ||
264 | 0 | _c20051006 | |
008 | 200510s 0 0 eng d | ||
022 | _a0741-5400 | ||
024 | 7 |
_a10.1189/jlb.0105017 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWesche, Doreen E | |
245 | 0 | 0 |
_aLeukocyte apoptosis and its significance in sepsis and shock. _h[electronic resource] |
260 |
_bJournal of leukocyte biology _cAug 2005 |
||
300 |
_a325-37 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _ximmunology |
650 | 0 | 4 | _aCaspase Inhibitors |
650 | 0 | 4 |
_aCaspases _ximmunology |
650 | 0 | 4 |
_aDendritic Cells _ximmunology |
650 | 0 | 4 |
_aEndothelial Cells _ximmunology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aFas Ligand Protein |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocytes _ximmunology |
650 | 0 | 4 |
_aMembrane Glycoproteins _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMultiple Organ Failure _xdrug therapy |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aRNA, Small Interfering _ximmunology |
650 | 0 | 4 |
_aSepsis _xdrug therapy |
650 | 0 | 4 |
_aShock, Septic _xdrug therapy |
650 | 0 | 4 |
_aSteroids _ximmunology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _ximmunology |
700 | 1 | _aLomas-Neira, Joanne L | |
700 | 1 | _aPerl, Mario | |
700 | 1 | _aChung, Chun-Shiang | |
700 | 1 | _aAyala, Alfred | |
773 | 0 |
_tJournal of leukocyte biology _gvol. 78 _gno. 2 _gp. 325-37 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1189/jlb.0105017 _zAvailable from publisher's website |
999 |
_c15487007 _d15487007 |